index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

56 Publications avec texte intégral

Open Access

46 %

Mots clés

Ectopic germinal centers PBMC Thymoma Lamin A/C nuclei Chronicity FMR1 Th17 cells Inflammatory cytokines Neuromuscular junction MYB Maladie auto-immune Acetylcholine receptor Centres germinatifs ectopiques Myoblasts Immune regulation Acides nucléiques endogènes Autoimmune disease Autoimmunity Ferrites Disease susceptibility Thymus Immunology and Microbiology Section Macrophages Transcriptome Acetylcholine receptor antibodies Myasthénie grave Interferon type I Long-term follow-up Acetylcholine receptors Early-onset myasthenia gravis Myasthenia gravis Glucocorticoids Experimental models Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Exercise CXCL13-CXCR5 Clinical cell transplantation Interferon Experimental autoimmune myasthenia gravis EAMG Cytokines Etiology Anticorps monoclonal Chemokines Max Experimental autoimmune myasthenia gravis Endogenous nucleic acids B cells Germinal center Chronic inflammation Cardiomyopathy BAFF Myasthenia Gravis MG Il-23 Interferon IFN Interferon-β Auto-immunité Innate immunity Thymic epithelial cells Autoimmune diseases Follicular hyperplasia Germinal centers Gender Age DICER Fragile X syndromes COVID-19 Interleukin 23 Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration CD31 Chemokine Heart failure Interferon type-I Interleukine-23 Inflammation Interferon de type I Immunity MG patients M3243AG Mass cytometry CyTOF Gd T cells Genetic associations Human myoblasts LMNA Cellules th17 Quality of life Immune response Immunotherapy Antimir-150 Genetics CTCF Interféron de type I AChR antibodies CCL21 Experimental mouse models Complete Freund's adjuvant Conduction disease Adaptive immunity Interferonopathy COX2 Animal models